Equillium Inc (EQ)
1.54
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
1.55
+0.01
(+0.65%)
After-Hours: 20:00
Equillium Cash from Operations (Quarterly): -8.80M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.80M |
| December 31, 2023 | -5.664M |
| September 30, 2023 | -1.909M |
| June 30, 2023 | -6.215M |
| March 31, 2023 | -7.995M |
| December 31, 2022 | 27.72M |
| September 30, 2022 | -13.06M |
| June 30, 2022 | -11.26M |
| March 31, 2022 | -12.13M |
| December 31, 2021 | -10.13M |
| September 30, 2021 | -7.01M |
| June 30, 2021 | -6.994M |
| March 31, 2021 | -7.944M |
| Date | Value |
|---|---|
| December 31, 2020 | -8.253M |
| September 30, 2020 | -4.921M |
| June 30, 2020 | -5.08M |
| March 31, 2020 | -6.37M |
| December 31, 2019 | -9.033M |
| September 30, 2019 | -4.696M |
| June 30, 2019 | -4.756M |
| March 31, 2019 | -4.464M |
| December 31, 2018 | -3.826M |
| September 30, 2018 | -1.642M |
| June 30, 2018 | -1.169M |
| March 31, 2018 | -0.889M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.06M
Minimum
Sep 2022
27.72M
Maximum
Dec 2022
-5.725M
Average
-7.002M
Median
Cash from Operations (Quarterly) Benchmarks
| Janux Therapeutics Inc | -14.84M |
| Mersana Therapeutics Inc | -32.66M |
| Vera Therapeutics Inc | -33.83M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -10.48M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.831M |
| Free Cash Flow | -22.66M |
| Free Cash Flow Per Share (Quarterly) | -0.2502 |
| Free Cash Flow to Equity (Quarterly) | -8.819M |
| Free Cash Flow to Firm (Quarterly) | -8.819M |
| Free Cash Flow Yield | -42.11% |